TERN-601

N/A

Report date: 2025/04/07 16:50:47
NME

Base Information

Drug NameTERN-601
Drug Alias NameTERN-601
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTerns Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTerns Pharmaceuticals IncShanghai Terns Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A